A tutorial on sensitivity analyses in clinical trials: the what, why, when and how

Type: Article

Publication Date: 2013-07-16

Citations: 722

DOI: https://doi.org/10.1186/1471-2288-13-92

Abstract

Sensitivity analyses play a crucial role in assessing the robustness of the findings or conclusions based on primary analyses of data in clinical trials. They are a critical way to assess the impact, effect or influence of key assumptions or variations—such as different methods of analysis, definitions of outcomes, protocol deviations, missing data, and outliers—on the overall conclusions of a study. The current paper is the second in a series of tutorial-type manuscripts intended to discuss and clarify aspects related to key methodological issues in the design and analysis of clinical trials. In this paper we will provide a detailed exploration of the key aspects of sensitivity analyses including: 1) what sensitivity analyses are, why they are needed, and how often they are used in practice; 2) the different types of sensitivity analyses that one can do, with examples from the literature; 3) some frequently asked questions about sensitivity analyses; and 4) some suggestions on how to report the results of sensitivity analyses in clinical trials. When reporting on a clinical trial, we recommend including planned or posthoc sensitivity analyses, the corresponding rationale and results along with the discussion of the consequences of these analyses on the overall findings of the study.

Locations

  • BMC Medical Research Methodology - View - PDF
  • PubMed Central - View
  • Europe PMC (PubMed Central) - View - PDF
  • uO Research (University of Ottawa) - View - PDF
  • PubMed - View

Similar Works

Action Title Year Authors
+ A brief overview of sensitivity analyses 2023 Allen R. Kunselman
+ PDF Chat Choosing sensitivity analyses for randomised trials: principles 2014 Tim P. Morris
Brennan C Kahan
Ian R. White
+ PDF Chat Sensitivity analysis in clinical trials: three criteria for a valid sensitivity analysis 2022 Sameer Parpia
Tim P. Morris
Mark Phillips
Charles C. Wykoff
David Steel
Lehana Thabane
Mohit Bhandari
Varun Chaudhary
Sobha Sivaprasad
Peter K. Kaiser
+ PDF Chat An introduction to multiplicity issues in clinical trials: the what, why, when and how 2016 Guowei Li
Monica Taljaard
Edwin R. van den Heuvel
Mitchell Levine
Deborah J. Cook
George A. Wells
P.J. Devereaux
Lehana Thabane
+ PDF Chat SAMURAI: Sensitivity analysis of a meta-analysis with unpublished but registered analytical investigations (software) 2014 Noory Y Kim
Shrikant I. Bangdiwala
Kylie Thaler
Gerald Gartlehner
+ Tutorial on statistical considerations on subgroup analysis in confirmatory clinical trials 2016 Mohamed Alosh
Mohammad F. Huque
Frank Bretz
Ralph B. D’Agostino
+ Sensitivity analysis for missing data in regulatory submissions 2015 Thomas Permutt
+ Sensitivity analyses assessing the impact of early stopping on systematic reviews: Recommendations for interpreting guidelines 2020 Ian C. Marschner
Lisa Askie
I. Manjula Schou
+ PDF Chat <i>Correction: Interpretation of CIs in clinical trials with non-significant results: systematic review and recommendations</i> 2017
+ PDF Chat Subgroup analyses in confirmatory clinical trials: time to be specific about their purposes 2016 Julien Tanniou
Ingeborg van der Tweel
Steven Teerenstra
Kit C. B. Roes
+ Comment: Incomplete Data in Clinical Studies: Analysis, Sensitivity, and Sensitivity Analysis 2009 Joseph G. Ibrahim
+ Estimands, Estimators and Sensitivity Analysis in Clinical Trials 2019 Craig Mallinckrodt
Geert Molenberghs
Ilya Lipkovich
Bohdana Ratitch
+ Sensitivity analysis approaches for incomplete longitudinal data in a multi-centre clinical trial 2019 Abdul‐Karim Iddrisu
+ PDF Chat Sensitivity Analysis in Observational Research: Introducing the E-Value 2017 Tyler J. VanderWeele
Peng Ding
+ An introduction to sample size calculations in clinical trials 2007 Simone Accordini
+ PDF Chat Comment on: Sensitivity Analysis for Not-at-Random Missing Data in Trial-Based Cost-Effectiveness Analysis: A Tutorial 2018 Baptiste Leurent
Manuel Gomes
James R. Carpenter
+ Intention-to-treat approach to data from randomized controlled trials: a sensitivity analysis 2003 Christine Wright
Julius Sim
+ PDF Chat Sample Size Calculation: Inaccurate A Priori Assumptions for Nuisance Parameters Can Greatly Affect the Power of a Randomized Controlled Trial 2015 Elsa Tavernier
Bruno Giraudeau
+ Data-Driven and Confirmatory Subgroup Analysis in Clinical Trials 2020 Alex Dmitrienko
Ilya Lipkovich
Aaron Dane
Christoph Muysers
+ PDF Chat Pre-specification of statistical analysis approaches in published clinical trial protocols was inadequate 2018 Lauren Greenberg
Vipul Jairath
Rupert M. Pearse
Brennan C Kahan

Works That Cite This (95)

Action Title Year Authors
+ PDF Chat Analysis of self-report and biochemically verified tobacco abstinence outcomes with missing data: a sensitivity analysis using two-stage imputation 2018 Yiwen Zhang
Xianghua Luo
Chap T. Le
Jasjit S. Ahluwalia
Janet L. Thomas
+ Statistical Guidelines for Handling Missing Data in Traumatic Brain Injury Clinical Research 2020 Jessica L. Nielson
Shelly R. Cooper
Seth A. Seabury
Davide Luciani
Anthony Fabio
Nancy Temkin
Adam R. Ferguson
Opeolu Adeoye
Neeraj Badjatia
Kim Boase
+ An empirical comparison of methods for analyzing over-dispersed zero-inflated count data from stratified cluster randomized trials 2020 Sayem Borhan
Courtney Kennedy
George Ioannidis
Αλεξάνδρα Παπαϊωάννου
Jonathan D. Adachi
Lehana Thabane
+ An empirical comparison of time-to-event models to analyse a composite outcome in the presence of death as a competing risk 2020 Ndamonaonghenda Haushona
Tonya M. Esterhuizen
Lehana Thabane
Rhoderick Machekano
+ PDF Chat Appropriate design and reporting of superiority, equivalence and non-inferiority clinical trials incorporating a benefit–risk assessment: the BRAINS study including expert workshop 2023 Nikki Totton
Steven A. Julious
Elizabeth Coates
Dyfrig Hughes
Jonathan Cook
Katie Biggs
Catherine Hewitt
Simon Day
Andrew Cook
+ PDF Chat A roadmap to using historical controls in clinical trials – by Drug Information Association Adaptive Design Scientific Working Group (DIA-ADSWG) 2020 Mercedeh Ghadessi
Rui Tang
Joey Tianyi Zhou
Rong Liu
Chenkun Wang
Kiichiro Toyoizumi
Chaoqun Mei
Lixia Zhang
C. Q. Deng
Robert A. Beckman
+ PDF Chat A systematic survey on reporting and methods for handling missing participant data for continuous outcomes in randomized controlled trials 2017 Yuqing Zhang
Iván D. Flórez
Luis Enrique Colunga‐Lozano
Fazila Aloweni
Sean A. Kennedy
Aihua Li
Samantha Craigie
Shiyuan Zhang
Arnav Agarwal
Luciane Cruz Lopes
+ A Procedure and Guidelines for Analyzing Groups of Software Engineering Replications 2020 Adrián Santos
Sira Vegas
Markku Oivo
Natália Juristo
+ PDF Chat An introduction to multiplicity issues in clinical trials: the what, why, when and how 2016 Guowei Li
Monica Taljaard
Edwin R. van den Heuvel
Mitchell Levine
Deborah J. Cook
George A. Wells
P.J. Devereaux
Lehana Thabane
+ PDF Chat Review of Recent Methodological Developments in Group-Randomized Trials: Part 2—Analysis 2017 Elizabeth L. Turner
Mélanie Prague
John A. Gallis
Fan Li
David M. Murray